scholarly journals Use of Imaging for Staging of Early-Stage Breast Cancer in Two Integrated Health Care Systems: Adherence With a Choosing Wisely Recommendation

2015 ◽  
Vol 11 (3) ◽  
pp. e320-e328 ◽  
Author(s):  
Erin E. Hahn ◽  
Tania Tang ◽  
Janet S. Lee ◽  
Corrine Munoz-Plaza ◽  
Joyce O. Adesina ◽  
...  

Use of imaging for staging of low-risk breast cancer was similar in both systems, and slightly lower than has been reported in the literature.

2014 ◽  
Vol 32 (30_suppl) ◽  
pp. 184-184
Author(s):  
Erin Elizabeth Hahn ◽  
Tania Tang ◽  
Janet S. Lee ◽  
Corrine Munoz-Plaza ◽  
Joyce O Adesina ◽  
...  

184 Background: The initial ASCO “Top 5” list, created as part of the Choosing Wisely campaign, recommends against use of imaging for staging of early stage breast cancer in asymptomatic women at low risk for metastasis. The objective of this study was to measure and compare use of imaging for staging in two large integrated health care systems, Kaiser Permanente (KP) and Intermountain Healthcare (IH). We also sought to distinguish whether imaging was used for routine staging or for diagnostic purposes. Methods: We identified stage 0-IIB breast cancer patients diagnosed between January 1, 2010 and December 31, 2012 with first primary malignancy from tumor registries in three KP regions (Southern California, Northwest, and Mid-Atlantic) and IH. Using the KP and IH electronic health records, we identified use of imaging tests (PET, CT, bone scan) during the staging window (30 days prior to diagnosis up to initial surgery). We performed chart abstraction on a random sample of patients who received an imaging test to identify indication. Results: For the total sample of 10,014, mean age at diagnosis was 60 (range 22-99); with 21% stage 0, 47% stage I, 32% stage II. Overall, 8% of patients (792 patients) received at least one imaging test during the staging window, including 8% at KP and 6% at IH (p=0.0005). Chart abstraction (N=129) revealed that overall, almost half of all imaging tests (48%) were performed to evaluate a symptom, sign or prior imaging finding, including 55% at KP and 32% at IH. Conclusions: Use of imaging for staging of low-risk breast cancer was very low in both health care systems, with clinically trivial differences between them. Approximately half of imaging services were in response to a sign or symptom. Strategies to reduce use of imaging at staging for early stage breast cancer patients within these health care systems are unlikely to yield meaningful improvement. [Table: see text]


2020 ◽  
Vol 30 (Supplement_5) ◽  
Author(s):  
E Riza ◽  
P Karnaki ◽  
D Zota ◽  
A Linos

Abstract The Mig-HealthCare Algorithm is a tool, comprising a set of questions developed with the aim to (a) guide the user on how to access all the categories and tools that are available through the Roadmap & Toolbox (b) help the user identify the health issues of importance when providing care to a specific migrant/refugee. At the end of a series of questions, a brief report summarizing the main outcomes is generated. The algorithm was tested in Greece in two mainland reception centres and a local hospital in an area serving migrants/refugees. Results discuss the usefulness of the algorithm for improving the delivery of appropriate health services to migrants/refugees and its importance in raising awareness about the health conditions which are crucial for migrants/refugees and are expected to pose a significant burden on the health care systems of host countries unless dealt with adequately at an early stage.


2019 ◽  
Vol 25 (2) ◽  
pp. 334-337
Author(s):  
Raeshell S. Sweeting ◽  
Liping Du ◽  
Yu Shyr ◽  
Mary A. Hooks

The Breast ◽  
2015 ◽  
Vol 24 ◽  
pp. S87-S88
Author(s):  
H. Ali ◽  
V. Dabak ◽  
H. Mccoy ◽  
C. Burmeister ◽  
W. Haykus ◽  
...  

2009 ◽  
Vol 64 (2) ◽  
pp. 100-112 ◽  
Author(s):  
I. Van Vlaenderen ◽  
J.L. Canon ◽  
V. Cocquyt ◽  
G. Jerusalem ◽  
J.P. Machiels ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document